levofloxacin has been researched along with Infections, Staphylococcal in 134 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (7.46) | 18.2507 |
| 2000's | 50 (37.31) | 29.6817 |
| 2010's | 57 (42.54) | 24.3611 |
| 2020's | 17 (12.69) | 2.80 |
| Authors | Studies |
|---|---|
| Frigola, J; García-Granda, S; Gómez-Gomar, A; Ortega, E; Torrens, A; Vañó, D | 1 |
| Appelbaum, PC; Bhawsar, SB; Bozdogan, B; de Souza, NJ; Desai, VN; Deshpande, PK; Gupte, SV; Hooper, DC; Jacobs, MR; Jha, R; Khorakiwala, HF; Patel, MV; Shetty, N; Shukla, MC; Strahilevitz, J; Yeole, RD | 1 |
| Cohen, DE; Kanaya, F; Mayer, KH; Szumowski, JD | 1 |
| Landmann, R; Murphy, CK; Rothstein, DM; Trampuz, A; Widmer, AF; Zimmerli, W | 1 |
| Clark, NC; Hageman, J; McDonald, LC; McDougal, LK; Patel, JB; Zhu, W | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Fowler, VG; Luperchio, SA; McCalla, C; Moise, PA; Robinson, DA; Sakoulas, G; Smyth, DS; Steenbergen, J | 1 |
| Ariza, J; Cabellos, C; Cabo, J; Euba, G; Gudiol, F; Murillo, O; Pachón, ME; Tubau, F; Verdaguer, R | 2 |
| Baldoni, D; Haschke, M; Rajacic, Z; Trampuz, A; Zimmerli, W | 1 |
| Hafkin, B; Hoban, DJ; Kaplan, N; Karlowsky, JA; Zhanel, GG | 1 |
| Chen, H; Chen, M; Liu, Y; Ma, Y; Nichols, WW; Sun, W; Wang, H; Zhang, J; Zhao, C | 1 |
| Banevicius, MA; Crandon, JL; Koomanachai, P; Nicolau, DP; Peng, L | 1 |
| Janechek, MJ; Jones, RN; Mendes, RE; Moet, GJ | 1 |
| Alm, R; Brassil, P; Breault, G; Breen, J; Comita-Prevoir, J; Cronin, M; Davis, H; Dejonge, B; Ehmann, D; Eyermann, CJ; Fisher, S; Galullo, V; Geng, B; Grebe, T; Hayter, B; Morningstar, M; Newman, J; Reck, F; Walker, P | 1 |
| Alm, RA; Barthlow, H; Brassil, P; Breen, J; Ciaccio, P; Comita-Prevoir, J; Cronin, M; Ehmann, DE; Fisher, SL; Geng, B; Godfrey, AA; Goteti, K; McNulty, J; Newman, JV; Reck, F | 1 |
| Anderson, BE; Burda, WN; Cormier, R; Edlinger, J; Harrington, L; Kapolka, R; Kodigepalli, KM; Roma, G; Shaw, LN; Thomas, J; Turos, E | 1 |
| Basarab, GS; Bist, S; Boriack-Sjodin, PA; Dangel, B; Eakin, AE; Illingworth, R; Manchester, JI; Sherer, BA; Sriram, S; Uria-Nickelsen, M | 1 |
| Alm, R; Basarab, GS; Bist, S; Dangel, PB; Eakin, AE; Garner, CE; Green, O; Hauck, S; Hill, PJ; Hull, K; Illingworth, R; Manchester, JI; Rooney, M; Sherer, BA; Uria-Nickelsen, M; Zhou, F | 1 |
| Basarab, GS; Brassil, P; Doig, P; Galullo, V; Gowravaram, M; Haimes, HB; Kern, G; Kutschke, A; McNulty, J; Schuck, VJ; Stone, G | 1 |
| Fukuda, H; Fukuda, Y; Kaelin, DE; Kishii, R; Kurasaki, H; Lagrutta, A; Meinke, PT; Miesel, L; Nishimura, A; Ohata, K; Olsen, DB; Peng, X; Shibata, T; Singh, SB; Takano, H; Takei, M; Takeuchi, T; Tan, CM; Wang, X; Wei, C; Wu, J | 1 |
| Fukuda, H; Fukuda, Y; Kaelin, DE; Kishii, R; Kurasaki, H; Lagrutta, A; Meinke, PT; Miesel, L; Nishimura, A; Ohata, K; Olsen, DB; Shibata, T; Singh, SB; Takano, H; Takei, M; Takeuchi, T; Tan, CM; Wu, J | 1 |
| Christo, SN; Griesser, HJ; Hayball, JD; Jasieniak, M; Mon, HH; Ndi, CP; Rickard, H; Semple, SJ | 1 |
| Aung, TT; Beuerman, RW; Cao, D; Koh, JJ; Lakshminarayanan, R; Li, J; Lim, F; Lin, S; Liu, S; Ren, L; Tan, DT; Verma, C; Wang, L; Wang, Y; Zou, H | 1 |
| Borra, RS; Chopra, S; Das, S; Dasgupta, A; Gatadi, S; Gour, J; Kaul, G; Madhavi, YV; Malasala, S; Nanduri, S; Shukla, M | 1 |
| Bhagwat, S; Bhawsar, S; Deshpande, P; Joshi, S; Patel, M; Yeole, R | 1 |
| Akhir, A; Chopra, S; Kaul, G; Meenu, MT; Radhakrishnan, KV; Shukla, M | 1 |
| Ashkbus, R; Collaud, A; Cottagnoud, M; Cottagnoud, P; Perreten, V; Sprenker, F | 1 |
| Chu, Y; Li, J; Liu, W; Prithiviraj, B; Wang, X; Wu, Y; Yang, X; Zeng, Q; Zhao, K; Zhou, H; Zhou, X | 1 |
| Chaves, F; Lora-Tamayo, J; Mancheño-Losa, M; Meléndez-Carmona, MÁ; Muñoz-Gallego, I; Ruiz-Sorribas, A; Van Bambeke, F; Viedma, E | 1 |
| Bartoszewicz, M; Brożyna, M; Dudek-Wicher, R; Dydak, K; Junka, A; Madziała, M; Oleksy-Wawrzyniak, M; Paleczny, J | 1 |
| Hou, G; Liu, T; Ma, W; Tian, F; Wang, J | 1 |
| Cai, H; Cao, Q; Chen, Y; Deng, H; Deng, J; Hao, J; He, L; Huang, Y; Jing, C; Lin, A; Wang, C; Wu, X; Xu, H; Yang, J; Yu, H; Zhang, T | 1 |
| Aziz Abdulhassan, A; Jasim Obeed, R; Saad Latteef, N; Salih, WY | 1 |
| Alcalá, FJC; Alonso, AR; Alonso, OZ; Calvo, C; de Villalta, MGF; García, LE; García-Boyano, M; Melero, IQ; Retolaza, IR | 1 |
| Gui, Z; Li, J; Li, M; Li, X; Ma, H; Ma, Z; Sun, G; Tang, Q; Ye, X; Zhang, B | 1 |
| Benedetto, C; Bertero, L; Borella, F; Carosso, A; Cosma, S; Fassio, F; Ingala, A; Maina, A; Robba, T | 1 |
| Jiang, M; Li, G; Wu, X; Xu, L | 1 |
| Dobashi, M; Ikeda, M; Ishii, J; Koguchi, D; Murakami, Y | 1 |
| Huang, H; Li, P; Liao, K; Liu, B; Liu, C; Su, W; Wang, Y; Zhou, Q | 1 |
| Abed El Jalil, K; Mehanna, MM; Mneimneh, AT | 1 |
| Abdelaziz, AA; El-Barrawy, MA; El-Nagar, RAM | 1 |
| Chang, YF; Cheng, YH; Ko, YC; Liu, CJ | 1 |
| Belubbi, T; Gupta, PV; Nagarsenker, MS; Nirwane, AM | 1 |
| Bori, G; Jutte, PC; Kampinga, GA; Morata, L; Nannan Panday, PV; Soriano, A; Tornero, E; Wouthuyzen-Bakker, M | 1 |
| Cicuéndez, M; Doadrio, JC; Hernández, A; Izquierdo-Barba, I; Portolés, MT; Vallet-Regí, M | 1 |
| Acosta-Robles, PJ; González-Vaquero, D; Juan Enrique Martínez-de la Plata, JE; Martos-Rosa, A; Morales-Molina, JA | 1 |
| Ilyas, AM; Kistler, JM; Thoder, JJ | 1 |
| Gupta, PV; Nagarsenker, MS; Nirwane, AM | 1 |
| Barion, U; Brescia, G; Munari, S; Zanotti, C | 1 |
| Bandyopadhyay, J; Patel, T; Ting, DSJ | 1 |
| Chen, PL; Hung, YP; Ko, WC; Lee, NY; Li, CW; Li, MC; Liu, CC; Syue, LS; Tang, HJ; Tsai, PF | 1 |
| Chu, CC; Han, H; Li, F; Wang, X; Wu, D; Yu, J; Zhu, J | 1 |
| Caroleo, B; Galasso, O; Gasparini, G; Mercurio, M | 1 |
| Chaves, F; Lora-Tamayo, J; Meléndez-Carmona, MÁ; Muñoz-Gallego, I; Viedma, E | 1 |
| Cheng, J; Hu, LF; Li, JB; Liu, LG; Ye, Y; Zhu, YL | 1 |
| Bart, G; Dernis, E; Derouet, N; Plat, M | 1 |
| Klein, EY; Laxminarayan, R; May, L; Rothman, RE | 1 |
| Koh, S; Maeda, N; Nishida, K | 1 |
| Coviello, T; D'Arrigo, G; Di Meo, C; Matricardi, P; Montanari, E; Passariello, C; Virga, A | 1 |
| Popov, SV | 1 |
| Guo, C; Han, S; Jiang, H; Liu, T; Wu, X | 1 |
| Fujii, T; Ito, A; Nakaminami, H; Noguchi, N; Utsumi, K | 1 |
| Ariza, J; Cabellos, C; Cabo, J; El Haj, C; Garcia-Somoza, D; Murillo, O; Ribera, A; Tubau, F; Vivas, M | 1 |
| Chang, SH; Chien, HI; Chien, ST; Hsu, CH; Hsueh, JC; Lee, PL; Lee, TM; Yang, MC; Yang, TF | 1 |
| Hassan, A; Hoffman, J | 1 |
| Bourgeois-Nicolaos, N; Cattoir, V; Decousser, JW; Desroches, M; Doucet-Populaire, F; Jehl, F; Lina, G; Potier, J; Vandenesh, F | 1 |
| Baba, T; Hiramatsu, K; Morimoto, Y; Sasaki, T | 1 |
| Ohashi, Y; Suzuki, T; Yamamoto, T | 1 |
| Attisano, C; Cibinel, M; Furfaro, G; Giardini, F; Grandi, G; Grignolo, FM; Machetta, F; Panepinto, G; Pollino, C; Strani, G | 1 |
| Iino, N; Koda, R; Watanabe, H | 1 |
| Bicart-See, A; Bonnet, E; Félicé, MP; Giordano, G; Lourtet-Hascoët, J | 1 |
| Joost, I; Kern, WV; Meyer, PT; Rieg, S; Steinfurt, J | 1 |
| Aguilar, L; Barberán, J; Carroquino, G; Giménez, MJ; Granizo, JJ; Prieto, J | 1 |
| Fokkens, WJ; Reitsma, JB; van Drunen, CM; Videler, WJ | 1 |
| Fantin, B; Massias, L; Muller-Serieys, C; Saleh Mghir, A | 1 |
| Basuino, L; Chambers, HF; Tattevin, P | 1 |
| Alişkan, H; Güçlü, M; Husamettin, E; Serin, E; Yakar, T | 1 |
| Ariza, J; Cabellos, C; Cabo, J; Carreras, M; Euba, G; Gudiol, F; Murillo, O; Pachón, ME; Verdaguer, R | 1 |
| Azzopardi, K; Finnin, B; Graichen, F; Hart, E; Jeffery, J; Mayadunne, R; Nijagal, B; O'Leary, S; O'Shea, M; Robins-Browne, R; Taing, H; Tait, R; Watkinson, R; Wickramaratna, M | 1 |
| Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
| Chen, H; Jiang, HR; Wu, XG; Xin, M; Yang, LN | 1 |
| Cervera, C; del Río, A; Fernández-Ruiz, M; Marco, F; Miró, JM; Moreno, A; Pérez, G; Pitart, C | 1 |
| Kim, SJ; Toma, HS | 1 |
| Naber, KG; Roscher, K; Wagenlehner, F | 1 |
| Chen, X; Guo, X; Shi, G; Wang, H; Wang, S; Zhang, X | 1 |
| Chen, H; Jiang, H; Liu, T; Song, Z; Wu, X; Xu, Y; Yang, L; Yue, W | 1 |
| Ceri, H; Gomes, F; Oliveira, R; Teixeira, P | 1 |
| Guo, YL; Jin, FS; Liu, DM; Shen, ZJ; Sun, YH; Zhang, ZC | 1 |
| Bensalem, M; Bland, S; Bru, JP; Gaillat, J; Garraffo, R; Guillaume, M; Janssen, C | 1 |
| Feng, L; Gao, Q; Huang, X; Jiang, Z; Li, Y; Lin, J; Lin, X; Liu, Y; Wang, T; Xie, Z | 1 |
| Taha, AB | 1 |
| Cirioni, O; D'Amato, G; Del Prete, M; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G | 1 |
| Marchetti, F; Trinchieri, A | 1 |
| Carpenter, TR; Kaufman, MB; McDonnell, PJ; Sarayba, MA; Sweet, PM; Taban, M; Tungsiripat, T | 1 |
| Cirioni, O; D'Amato, G; Del Prete, MS; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C | 1 |
| Matoba, AY | 1 |
| Dehghanyar, P; Georgopoulos, A; Heinz, G; Joukhadar, C; Mayer, BX; Müller, M; Neckel, U; Schenk, BS; Zeitlinger, MA | 1 |
| Entenza, JM; Glauser, MP; Moreillon, P; Vouillamoz, J | 2 |
| Alfonso, EC; Marangon, FB; Miller, D; Muallem, MS; Romano, AC | 1 |
| Dajcs, JJ; Girgis, DO; Marquart, ME; O'Callaghan, RJ; Thibodeaux, BA; Traidej, M | 1 |
| Arnold, FW; Wojda, B | 1 |
| Gehanno, P; Pessey, JJ; Serrano, E | 1 |
| Barton, TD; Fishman, NO; Lautenbach, E; Quain, RD; Weiner, MG | 1 |
| Asan, A; Baltalarli, A; Cevahir, N; Goksin, I; Kaleli, I; Sacar, M; Sacar, S; Tekin, K; Toprak, S; Turgut, H | 1 |
| Järvinen, A; Kauma, H; Koivula, I; Kotilainen, P; Lumio, J; Nikoskelainen, J; Rintala, E; Ruotsalainen, E; Vaara, M; Valtonen, V | 1 |
| Bayar, B; Bozkurt, A; Dinçel, A; Duman, S; Kaya, E; Oflu, Y; Yağci, R; Yağci, S | 1 |
| Cars, O; Odenholt, I | 1 |
| Ariza, J; Cabellos, C; Doménech, A; Garcia, A; Gudiol, F; Murillo, O; Tubau, F | 1 |
| Aguilar, L; Barberán, J; Carroquino, G; Giménez, MJ; Martínez, D; Prieto, J; Sánchez, B | 1 |
| Cui, J; Drlica, K; Liu, Y; Tong, W; Wang, R; Zhao, X | 1 |
| Cantón, E; Colombo Gainza, E; Gil Brusola, A; Gobernado, M; Ortiz Estévez, R; Sahuquillo Arce, JM | 1 |
| Dubois, V; Grellet, J; Nguyen, HA; Quentin, C; Saux, MC | 1 |
| Cheng, GF; Gu, CQ; Hu, XY; Li, XM; Wang, DH; Zhou, Q; Zhou, SQ | 1 |
| Foo, SS; Lye, DC | 1 |
| De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L | 1 |
| Abad, JL; Alió, JL; Fernandez, J; Ferrer, C; Rodríguez, A | 1 |
| Inoue, T; Kida, T; Naka, H; Sakaki, H; Tokushige, H; Wada, T | 1 |
| Barrett, JF; Frosco, MB; Kulwich, BA; Licata, L; Melton, JL; Stewart, FP | 1 |
| Jasovich, A; Neto, W; Nicodemo, AC; Robledo, JA | 1 |
| Akiyama, H; Arata, J; Kanzaki, H; Tada, J; Yamasaki, O | 1 |
| Aeschlimann, JR; Dresser, LD; Kaatz, GW; Rybak, MJ | 1 |
| Fujimoto, K; Mizuno, K; Nabeshima, T; Ohta, M; Osada, T; Sakurai, T; Yamamura, K | 1 |
| Aeschlimann, JR; Kaatz, GW; Rybak, MJ | 1 |
| Chambers, HF; Chow, LL; Hackbarth, C; Xiang, Q | 1 |
| Rajacic, Z; Trampuz, A; Wenk, M; Zimmerli, W | 1 |
| Almela, M; Alvárez, JL; García, S; Mensa, J; Ortega, M; Soriano, A; Soriano, E; Tomás, X | 1 |
| Boccoli, G; Cirioni, O; Ghiselli, R; Giacometti, A; Goffi, L; Mocchegiani, F; Riva, A; Saba, V; Scalise, G | 1 |
| Calhoun, JH; Mader, JT; Shirtliff, ME | 1 |
| Bisognano, C; Francois, P; Lew, DP; Schrenzel, J; Vaudaux, P | 1 |
| Graffunder, EM; Venezia, RA | 1 |
| Cirioni, O; Ghiselli, R; Giacometti, A; Mocchegiani, F; Riva, A; Saba, V; Scalise, G | 1 |
| Abe, Y; Akiyama, H; Arata, J; Kanzaki, H; Katayama, H; Nishihara, O; Shimoe, K; Torigoe, R; Umemura, S; Yamada, T | 1 |
4 review(s) available for levofloxacin and Infections, Staphylococcal
| Article | Year |
|---|---|
Osteomyelitis of the pubic symphysis caused by methicillin-resistant Staphylococcus aureus after vaginal delivery: a case report and literature review.
Topics: Adult; Anti-Bacterial Agents; Delivery, Obstetric; Female; Fever; Humans; Levofloxacin; Magnetic Resonance Imaging; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Osteomyelitis; Postpartum Period; Pregnancy; Pseudomonas aeruginosa; Pubic Symphysis; Rare Diseases; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2019 |
MRSA Incidence and Antibiotic Trends in Urban Hand Infections: A 10-Year Longitudinal Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bites and Stings; Clindamycin; Coinfection; Drug Resistance, Bacterial; Female; Hand; Humans; Incidence; Levofloxacin; Longitudinal Studies; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Staphylococcal Infections; Substance Abuse, Intravenous; Wounds and Injuries; Young Adult | 2019 |
[Post-partum infectious sacroiliitis].
Topics: Adult; Bacteremia; Drug Therapy, Combination; Emergencies; Female; Humans; Levofloxacin; Magnetic Resonance Imaging; Pregnancy; Psoas Abscess; Puerperal Disorders; Rifampin; Sacroiliitis; Staphylococcal Infections | 2013 |
[Rational antimicrobial therapy of chronic bacterial prostatitis].
Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Prostate; Prostatitis; Staphylococcal Infections; Staphylococcus; Treatment Outcome | 2013 |
9 trial(s) available for levofloxacin and Infections, Staphylococcal
| Article | Year |
|---|---|
Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Daptomycin; Endocarditis, Bacterial; Genotype; Hemolysin Proteins; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2008 |
Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacitracin; Chronic Disease; Colistin; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Middle Aged; Nebulizers and Vaporizers; Ofloxacin; Pilot Projects; Rhinitis; Sinusitis; Staphylococcal Infections; Staphylococcus aureus | 2008 |
Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Azithromycin; Conjunctiva; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Intravitreal Injections; Levofloxacin; Middle Aged; Moxifloxacin; Nasopharynx; Ofloxacin; Prospective Studies; Quinolines; Staphylococcal Infections | 2011 |
Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients.
Topics: Adult; Anti-Bacterial Agents; Asian People; Ciprofloxacin; Escherichia coli Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome | 2012 |
[Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections].
Topics: Anti-Infective Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Follow-Up Studies; Humans; Levofloxacin; Ofloxacin; Pseudomonas Infections; Recurrence; Safety; Staphylococcal Infections; Streptococcal Infections; Superinfection; Treatment Outcome; Urinary Tract; Urinary Tract Infections | 2003 |
[Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications].
Topics: Acute Disease; Adolescent; Adult; Africa, Southern; Aged; Bacterial Infections; Female; France; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Male; Middle Aged; Moraxella catarrhalis; Moraxellaceae Infections; Ofloxacin; Pneumococcal Infections; Prospective Studies; Risk; Sinusitis; Staphylococcal Infections; Treatment Outcome; Tunisia | 2005 |
Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Chi-Square Distribution; Drug Therapy, Combination; Female; Finland; Humans; Levofloxacin; Male; Middle Aged; Odds Ratio; Ofloxacin; Penicillins; Prospective Studies; Rifampin; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Treatment Failure | 2006 |
A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Skin Diseases, Bacterial; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome | 1998 |
[Tolerability and safety of levofloxacinin long-term treatment].
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Female; Humans; Levofloxacin; Long-Term Care; Male; Middle Aged; Ofloxacin; Osteomyelitis; Prosthesis-Related Infections; Staphylococcal Infections | 2000 |
121 other study(ies) available for levofloxacin and Infections, Staphylococcal
| Article | Year |
|---|---|
7-Azetidinylquinolones as antibacterial agents. 3. Synthesis, properties and structure-activity relationships of the stereoisomers containing a 7-(3-amino-2-methyl-1-azetidinyl) moiety.
Topics: Animals; Anti-Bacterial Agents; Azetidinecarboxylic Acid; Chemical Phenomena; Chemistry, Physical; Crystallography, X-Ray; Escherichia coli Infections; Mice; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas Infections; Quinolones; Staphylococcal Infections; Stereoisomerism; Structure-Activity Relationship | 1995 |
A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Clinical Trials, Phase I as Topic; Dogs; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Mutation; Prodrugs; Quinolizines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vancomycin Resistance | 2005 |
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Boston; Female; HIV Infections; Humans; Male; Methicillin Resistance; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome | 2007 |
Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Foreign-Body Reaction; Guinea Pigs; Injections, Intraperitoneal; Levofloxacin; Male; Microbial Sensitivity Tests; Molecular Structure; Ofloxacin; Rifampin; Rifamycins; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 2007 |
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Conjugation, Genetic; DNA Transposable Elements; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Humans; Michigan; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Restriction Mapping; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2008 |
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States | 2008 |
Antagonistic effect of rifampin on the efficacy of high-dose levofloxacin in staphylococcal experimental foreign-body infection.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Dose-Response Relationship, Drug; Drug Interactions; Foreign Bodies; Levofloxacin; Male; Ofloxacin; Prosthesis-Related Infections; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 2008 |
Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Therapy, Combination; Foreign-Body Reaction; Guinea Pigs; Injections, Intraperitoneal; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Animal; Oxazolidinones; Plankton; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 2009 |
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
Topics: Anti-Bacterial Agents; Benzofurans; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enterobacteriaceae; Enterococcus; Microbial Sensitivity Tests; Moraxella catarrhalis; Pyrones; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae | 2009 |
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
Topics: Anti-Bacterial Agents; China; Cities; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2009 |
Pharmacodynamic profile of tigecycline against methicillin-resistant Staphylococcus aureus in an experimental pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Female; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Minocycline; Pneumonia; Staphylococcal Infections; Tigecycline | 2009 |
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Linezolid; Lipoglycopeptides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin | 2010 |
Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II: broad-spectrum antibacterial agents with reduced hERG activity.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; DNA Topoisomerases, Type II; Dogs; Drug Resistance, Bacterial; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Models, Molecular; Piperidines; Protein Conformation; Rats; Staphylococcal Infections; Structure-Activity Relationship; Topoisomerase Inhibitors | 2011 |
Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II with reduced pK(a): antibacterial agents with an improved safety profile.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Dioxanes; DNA Topoisomerase IV; Dogs; Drug Resistance, Bacterial; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Piperidines; Quinolones; Staphylococcal Infections; Stereoisomerism; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2012 |
Studies on the antimicrobial properties of N-acylated ciprofloxacins.
Topics: Acylation; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bartonella; Bartonella Infections; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections | 2012 |
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents.
Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Bacteria; Disease Models, Animal; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Discovery; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Staphylococcal Infections; Structure-Activity Relationship; Topoisomerase II Inhibitors; Urea | 2013 |
Optimization of pyrrolamide topoisomerase II inhibitors toward identification of an antibacterial clinical candidate (AZD5099).
Topics: Adenosine Triphosphatases; Amides; Animals; Anti-Bacterial Agents; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Mice; Mice, Knockout; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pyrroles; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles; Topoisomerase II Inhibitors | 2014 |
Novel DNA gyrase inhibiting spiropyrimidinetriones with a benzisoxazole scaffold: SAR and in vivo characterization.
Topics: Animals; Anti-Bacterial Agents; Barbiturates; Female; Fluoroquinolones; Heterocyclic Compounds, 4 or More Rings; Humans; Inhibitory Concentration 50; Isoxazoles; Male; Mice; Pyridones; Rats, Wistar; Spiro Compounds; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2014 |
Structure activity relationship of substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-4).
Topics: Animals; DNA Topoisomerases; Mice; Molecular Structure; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Topoisomerase Inhibitors | 2015 |
Structure activity relationship of C-2 ether substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-5).
Topics: Animals; Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Cyclooctanes; DNA Gyrase; Drug Evaluation, Preclinical; Enterococcus faecium; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Mice, Inbred C57BL; Microbial Sensitivity Tests; Naphthyridines; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2015 |
Serrulatane Diterpenoid from Eremophila neglecta Exhibits Bacterial Biofilm Dispersion and Inhibits Release of Pro-inflammatory Cytokines from Activated Macrophages.
Topics: Animals; Anti-Bacterial Agents; Australia; Biofilms; Cell Survival; Cytokines; Diterpenes; Dose-Response Relationship, Drug; Eremophila Plant; Interleukin-1beta; Interleukin-6; Levofloxacin; Lipopolysaccharides; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Plants, Medicinal; Scrophulariaceae; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Tumor Necrosis Factor-alpha | 2015 |
Symmetrically Substituted Xanthone Amphiphiles Combat Gram-Positive Bacterial Resistance with Enhanced Membrane Selectivity.
Topics: Animals; Anti-Bacterial Agents; Cornea; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Staphylococcal Infections; Surface-Active Agents; Xanthones | 2017 |
Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Quinazolinones; Staphylococcal Infections; Structure-Activity Relationship; Triazoles | 2018 |
WCK 1152, WCK 1153: Discovery and structure activity relationship for the treatment of resistant pneumococcal and staphylococcal respiratory infections.
Topics: Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperidines; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus; Streptococcus pneumoniae; Structure-Activity Relationship | 2022 |
Developing the Natural Prenylflavone Artocarpin from
Topics: Animals; Anti-Bacterial Agents; Artocarpus; Biofilms; Flavonoids; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Addition of daptomycin to levofloxacin increased the efficacy of levofloxacin monotherapy against a methicillin-susceptible
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Levofloxacin; Meningitis; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Subinhibitory Cefotaxime and Levofloxacin Concentrations Contribute to Selection of Pseudomonas aeruginosa in Coculture with Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefotaxime; Coculture Techniques; Coinfection; Humans; Levofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Strain-to-strain variability among Staphylococcus aureus causing prosthetic joint infection drives heterogeneity in response to levofloxacin and rifampicin.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Biofilms; Humans; Levofloxacin; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 2022 |
The Medium Composition Impacts
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2022 |
Evaluation of the effect of gentamicin in surgical perfusion solution on cataract postoperative endophthalmitis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cataract; Endophthalmitis; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Perfusion; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Antimicrobial resistance profile of methicillin-resistant
Topics: Abscess; Anti-Bacterial Agents; Child; Child, Preschool; Clindamycin; Communicable Diseases; Drug Resistance, Bacterial; Erythromycin; Gentamicins; Humans; Infant, Newborn; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Evaluation of Gene Expression of
Topics: Bacterial Proteins; Ciprofloxacin; Gene Expression; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Multidrug Resistance-Associated Proteins; RNA, Ribosomal, 16S; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Microbiological patterns of bacterial infections in tracheostomized children: Reducing uncertainty in continuous care.
Topics: Adolescent; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Escherichia coli; Follow-Up Studies; Humans; Imipenem; Klebsiella pneumoniae; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Respiratory Tract Infections; Retrospective Studies; Staphylococcal Infections; Uncertainty | 2023 |
8-octyl berberine combats Staphylococcus aureus by preventing peptidoglycan synthesis.
Topics: Anti-Bacterial Agents; Berberine; Humans; Levofloxacin; Microbial Sensitivity Tests; Molecular Docking Simulation; Peptidoglycan; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Eye drops and eye gels of levofloxacin: comparison of ocular absorption characterizations and therapeutic effects in the treatment of bacterial keratitis in rabbits.
Topics: Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Gels; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Ocular Absorption; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2020 |
Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Cefaclor; Cefazolin; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Fosfomycin; Humans; Klebsiella Infections; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Proteus Infections; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult | 2020 |
Pithecellobium clypearia extract enriched in gallic acid and luteolin has antibacterial activity against MRSA and reduces resistance to erythromycin, ceftriaxone sodium and levofloxacin.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Fabaceae; Gallic Acid; Levofloxacin; Luteolin; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Plant Extracts; Staphylococcal Infections; Tandem Mass Spectrometry | 2020 |
Levofloxacin-loaded naturally occurring monoterpene-based nanoemulgel: a feasible efficient system to circumvent MRSA ocular infections.
Topics: Anti-Bacterial Agents; Eye Infections; Fluoroquinolones; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monoterpenes; Staphylococcal Infections | 2020 |
Potent synergistic combination of rosuvastatin and levofloxacin against Staphylococcus aureus: in vitro and in vivo study.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Biofilms; Coagulase; Disease Models, Animal; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Hemolysin Proteins; Levofloxacin; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Rosuvastatin Calcium; Sphingomyelin Phosphodiesterase; Staphylococcal Infections; Staphylococcus aureus; Virulence Factors; Wound Infection | 2021 |
Development of a dual delivery of levofloxacin and prednisolone acetate via PLGA nanoparticles/ thermosensitive chitosan-based hydrogel for postoperative management: An in-vitro and ex-vivo study.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cell Survival; Cells, Cultured; Chitosan; Cytokines; Disease Models, Animal; Drug Carriers; Drug Liberation; Drug Therapy, Combination; Endophthalmitis; Epithelial Cells; Epithelium, Corneal; Hydrogels; Keratitis; Levofloxacin; Nanoparticles; Particle Size; Postoperative Complications; Prednisolone; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Temperature | 2021 |
Pulmonary delivery of synergistic combination of fluoroquinolone antibiotic complemented with proteolytic enzyme: A novel antimicrobial and antibiofilm strategy.
Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Biofilms; Drug Combinations; Drug Synergism; Female; Levofloxacin; Liposomes; Lung; Microbial Sensitivity Tests; Peptide Hydrolases; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus | 2017 |
Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus.
Topics: Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Moxifloxacin; Prosthesis-Related Infections; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2018 |
Multifunctional pH sensitive 3D scaffolds for treatment and prevention of bone infection.
Topics: 3T3 Cells; Animals; Anti-Bacterial Agents; Biocompatible Materials; Biofilms; Bone Regeneration; Cell Line; Coculture Techniques; Culture Media; Humans; Hydrogen-Ion Concentration; L-Lactate Dehydrogenase; Levofloxacin; Mice; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Osteoblasts; Osteomyelitis; Porosity; Reactive Oxygen Species; Spectroscopy, Fourier Transform Infrared; Staphylococcal Infections; Staphylococcus aureus; Tissue Scaffolds; X-Ray Diffraction | 2018 |
[Delayed pancytopenia due to treatment with levofloxacin: A case report].
Topics: Aged; Anti-Bacterial Agents; Female; Humans; Levofloxacin; Pancytopenia; Prosthesis-Related Infections; Staphylococcal Infections | 2018 |
Inhalable Levofloxacin Liposomes Complemented with Lysozyme for Treatment of Pulmonary Infection in Rats: Effective Antimicrobial and Antibiofilm Strategy.
Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Biofilms; Drug Therapy, Combination; Levofloxacin; Liposomes; Lung Diseases; Muramidase; Rats; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus | 2018 |
Burkholderia gladioli sinonasal infection.
Topics: Anti-Bacterial Agents; Burkholderia gladioli; Burkholderia Infections; Endoscopy; Female; Humans; Immunocompetence; Levofloxacin; Maxillary Sinusitis; Middle Aged; Rhinitis; Staphylococcal Infections; Travel-Related Illness | 2019 |
Microbial keratitis complicated by acute hydrops following corneal collagen cross-linking for keratoconus.
Topics: Anti-Bacterial Agents; Collagen; Corneal Edema; Corneal Pachymetry; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Dexamethasone; Drug Therapy, Combination; Eye Infections, Bacterial; Glucocorticoids; Humans; Keratoconus; Levofloxacin; Male; Photochemotherapy; Photosensitizing Agents; Riboflavin; Slit Lamp Microscopy; Staphylococcal Infections; Staphylococcus aureus; Visual Acuity; Young Adult | 2019 |
Bloodstream infections in hospitalized adults with dengue fever: Clinical characteristics and recommended empirical therapy.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Candidemia; Cefepime; Coinfection; Dengue; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Hospitals; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Staphylococcal Infections; Streptococcus; Taiwan | 2019 |
Self-assembly of amino acid-based random copolymers for antibacterial application and infection treatment as nanocarriers.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Drug Carriers; Drug Liberation; Esterification; HeLa Cells; Humans; Levofloxacin; Male; Mice; Mice, Inbred C57BL; Micelles; Nylons; Staphylococcal Infections; Staphylococcus aureus | 2019 |
Cervical spondylodiscitis mimicking Pott's disease: a case report.
Topics: Aged; Anti-Bacterial Agents; Cervical Vertebrae; Discitis; Humans; Levofloxacin; Magnetic Resonance Imaging; Male; Staphylococcal Infections; Teicoplanin; Tuberculosis, Spinal | 2019 |
Intraosteoblastic activity of levofloxacin and rifampin alone and in combination against clinical isolates of meticillin-susceptible Staphylococcus aureus causing prosthetic joint infection.
Topics: Anti-Bacterial Agents; Cell Line; Colony Count, Microbial; Humans; Levofloxacin; Microbial Sensitivity Tests; Microbial Viability; Models, Theoretical; Osteoarthritis; Osteoblasts; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 2019 |
Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Genes, Bacterial; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2013 |
Trends in antibiotic resistance in coagulase-negative staphylococci in the United States, 1999 to 2012.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Staphylococcal Infections; Staphylococcus epidermidis; United States | 2014 |
Visualization of the meibomian glands by means of noncontact mobile-type meibography (Meibopen) in a 16-year-old girl with unilateral marginal staphylococcal keratitis.
Topics: Administration, Oral; Administration, Topical; Adolescent; Anti-Bacterial Agents; Clarithromycin; Corneal Ulcer; Diagnostic Techniques, Ophthalmological; Drug Therapy, Combination; Eye Infections, Bacterial; Eyelid Diseases; Female; Fluorometholone; Humans; Levofloxacin; Meibomian Glands; Staphylococcal Infections; Visual Acuity | 2014 |
Chasing bacteria within the cells using levofloxacin-loaded hyaluronic acid nanohydrogels.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Cholesterol; Drug Delivery Systems; Fluoroquinolones; HeLa Cells; Humans; Hyaluronic Acid; Hydrogels; Levofloxacin; Nanostructures; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 2014 |
In vitro and in vivo effectiveness evaluation of balofloxacin in experimental Staphylococcus aureus keratitis.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2014 |
Increase in SCCmec type IV strains affects trends in antibiograms of meticillin-resistant Staphylococcus aureus at a tertiary-care hospital.
Topics: Bacterial Toxins; Bacterial Typing Techniques; Cefotaxime; Chromosomes, Bacterial; Clarithromycin; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterotoxins; Exotoxins; Humans; Interspersed Repetitive Sequences; Japan; Leukocidins; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Staphylococcal Infections; Superantigens; Tertiary Care Centers; Virulence Factors | 2015 |
Daptomycin combinations as alternative therapies in experimental foreign-body infection caused by meticillin-susceptible Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Complementary Therapies; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Foreign Bodies; Levofloxacin; Male; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2015 |
Molecular Characterization of Community- and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Isolates in Southern Taiwan.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Moxifloxacin; Staphylococcal Infections; Taiwan | 2015 |
Severe staphylococcal marginal keratitis presenting with hypopyon.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Female; Humans; Iridocyclitis; Keratitis; Levofloxacin; Staphylococcal Infections; Ultrasonography | 2015 |
Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Coagulase; Drug Resistance, Multiple, Bacterial; France; Fusidic Acid; Gentamicins; Hospitals; Humans; Levofloxacin; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prospective Studies; Rifampin; RNA, Ribosomal, 23S; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcal Infections; Staphylococcus epidermidis | 2015 |
Apigenin as an anti-quinolone-resistance antibiotic.
Topics: Anti-Bacterial Agents; Apigenin; Base Sequence; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Genome, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Quinolones; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus; Topoisomerase II Inhibitors | 2015 |
The antibacterial activity of levofloxacin eye drops against staphylococci using an in vitro pharmacokinetic model in the bulbar conjunctiva.
Topics: Animals; Anti-Bacterial Agents; Conjunctiva; Conjunctivitis, Bacterial; Disease Models, Animal; Drug Resistance, Bacterial; Levofloxacin; Male; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis | 2016 |
Severe Ocular Bacterial Infections: A Retrospective Study Over 13 Years.
Topics: Anti-Bacterial Agents; Conjunctiva; Eye Infections, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus | 2017 |
Mycotic Aneurysm of the Abdominal Aorta Complicated With Iliopsoas Abscess and Infectious Spondylodiscitis in a Long-Term Hemodialyzed Patient: A Rare but Serious Complication of Staphylococcus Aureus Bacteremia.
Topics: Aneurysm, Infected; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Bacteremia; Cefazolin; Ceftriaxone; Discitis; Drainage; Humans; Levofloxacin; Male; Middle Aged; Psoas Abscess; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Staphylococcus lugdunensis, a serious pathogen in periprosthetic joint infections: comparison to Staphylococcus aureus and Staphylococcus epidermidis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Humans; Joint Prosthesis; Levofloxacin; Male; Middle Aged; Prosthesis-Related Infections; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Staphylococcus lugdunensis; Treatment Outcome | 2016 |
Staphylococcus aureus bacteremia with iliac artery endarteritis in a patient receiving ustekinumab.
Topics: Administration, Intravenous; Administration, Oral; Arthritis, Psoriatic; Bacteremia; Dermatologic Agents; Endarteritis; Female; Floxacillin; Humans; Iliac Artery; Levofloxacin; Middle Aged; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Ustekinumab | 2016 |
Levofloxacin plus rifampicin conservative treatment of 25 early staphylococcal infections of osteosynthetic devices for rigid internal fixation.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coagulase; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Orthopedic Fixation Devices; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2008 |
High doses of levofloxacin vs moxifloxacin against staphylococcal experimental foreign-body infection: the effect of higher MIC-related pharmacokinetic parameters on efficacy.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Fluoroquinolones; Foreign Bodies; Levofloxacin; Male; Microbial Sensitivity Tests; Microbial Viability; Models, Animal; Moxifloxacin; Ofloxacin; Quinolines; Rats; Rats, Wistar; Staphylococcal Infections; Time Factors | 2009 |
Bactericidal activity of the combination of levofloxacin with rifampin in experimental prosthetic knee infection in rabbits due to methicillin-susceptible Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Therapy, Combination; Humans; Knee Prosthesis; Levofloxacin; Methicillin; Microbial Sensitivity Tests; Ofloxacin; Prosthesis-Related Infections; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2009 |
Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated response.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Community-Acquired Infections; DNA Gyrase; DNA Mutational Analysis; DNA Transposable Elements; Fluoroquinolones; Gene Expression Profiling; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Ofloxacin; Penicillin-Binding Proteins; Selection, Genetic; SOS Response, Genetics; Staphylococcal Infections; Transcription Factors; Up-Regulation | 2009 |
A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefepime; Cefotaxime; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Escherichia coli Infections; Female; Humans; Infusions, Intravenous; Klebsiella Infections; Klebsiella pneumoniae; Leukocyte Count; Levofloxacin; Liver Cirrhosis; Male; Microbial Sensitivity Tests; Middle Aged; Neutrophils; Ofloxacin; Peritonitis; Pneumococcal Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections | 2010 |
Intracellular antimicrobial activity appearing as a relevant factor in antibiotic efficacy against an experimental foreign-body infection caused by Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Cloxacillin; Colony Count, Microbial; Cytoplasm; Disease Models, Animal; Foreign Bodies; Levofloxacin; Ofloxacin; Rats; Staphylococcal Infections; Staphylococcus aureus | 2009 |
Efficacy of antimicrobial polymer coatings in an animal model of bacterial infection associated with foreign body implants.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Female; Foreign Bodies; Humans; Levofloxacin; Mice; Mice, Inbred BALB C; Ofloxacin; Polymers; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus | 2010 |
Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2010 |
Novel mucoadhesive polysaccharide isolated from Bletilla striata improves the intraocular penetration and efficacy of levofloxacin in the topical treatment of experimental bacterial keratitis.
Topics: Absorption; Administration, Topical; Animals; Anti-Bacterial Agents; Aqueous Humor; Bacterial Load; Biological Availability; Cell Line; Cell Proliferation; Cornea; Disease Models, Animal; Endothelial Cells; Eye; Female; Humans; Keratitis; Levofloxacin; Male; Ofloxacin; Ophthalmic Solutions; Orchidaceae; Plant Extracts; Polysaccharides; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tears; Treatment Outcome | 2010 |
Community-acquired methicillin-resistant Staphylococcus aureus meningitis complicated by cerebral infarction. Role of antibiotic combination of linezolid plus levofloxacin.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Cerebral Infarction; Community-Acquired Infections; Drug Therapy, Combination; Humans; Levofloxacin; Linezolid; Male; Meningitis, Bacterial; Methicillin-Resistant Staphylococcus aureus; Ofloxacin; Oxazolidinones; Staphylococcal Infections | 2010 |
[Practice management of chronic bacterial prostatitis with levofloxacin].
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Bacterial Infections; Chronic Disease; Escherichia coli Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Prostatitis; Recurrence; Staphylococcal Infections | 2011 |
Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Cell Line; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Space; Fluoroquinolones; Intracellular Space; Levofloxacin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Peritonitis; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 2012 |
Efficacy of gemifloxacin for the treatment of experimental Staphylococcus aureus keratitis.
Topics: Animals; Anti-Infective Agents, Local; Colony Count, Microbial; Conjunctival Diseases; Cornea; Eye; Female; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Keratitis; Levofloxacin; Male; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2012 |
Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms.
Topics: Biofilms; Clindamycin; Drug Combinations; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis | 2012 |
Pharmacokinetic and dynamic study of levofloxacin and rifampicin in bone and joint infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Arthritis, Infectious; Body Mass Index; Discitis; Dose-Response Relationship, Drug; Female; Fracture Fixation, Internal; Gastrointestinal Diseases; Humans; Levofloxacin; Male; Middle Aged; Musculoskeletal Diseases; Ofloxacin; Osteitis; Prospective Studies; Prosthesis-Related Infections; Rifampin; Sacroiliitis; Staphylococcal Infections; Surgical Wound Infection | 2012 |
A preliminary study to treat severe endophthalmitis via a foldable capsular vitreous body with sustained levofloxacin release in rabbits.
Topics: Animals; Anti-Bacterial Agents; Ciliary Body; Colony Count, Microbial; Cytokines; Drug Delivery Systems; Drug Implants; Endophthalmitis; Eye Infections, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rabbits; Real-Time Polymerase Chain Reaction; RNA, Messenger; Staphylococcal Infections; Staphylococcus epidermidis; Vitreous Body | 2013 |
Relationship and susceptibility profile of Staphylococcus aureus infection diabetic foot ulcers with Staphylococcus aureus nasal carriage.
Topics: Adult; Aged; Anti-Bacterial Agents; Carrier State; Diabetic Foot; Female; Humans; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Nose; Ofloxacin; Rifampin; Risk Factors; Staphylococcal Infections | 2013 |
Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Disease Models, Animal; Doxycycline; Drug Therapy, Combination; Injections, Intraperitoneal; Levofloxacin; Male; Ofloxacin; Polyesters; Prosthesis-Related Infections; Rats; Staphylococcal Infections; Staphylococcus epidermidis; Virginiamycin | 2002 |
Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Keratitis; Keratomileusis, Laser In Situ; Levofloxacin; Ofloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Surgical Flaps | 2003 |
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides.
Topics: Acetamides; Animals; Antibiotic Prophylaxis; Drug Resistance, Bacterial; Drug Therapy, Combination; Glycopeptides; Graft Rejection; Levofloxacin; Linezolid; Male; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2003 |
Polymicrobial keratitis secondary to Burkholderia ambifaria, enterococcus, and staphylococcus aureus in a patient with herpetic stromal keratitis.
Topics: Amikacin; Burkholderia; Burkholderia Infections; Corneal Stroma; Drug Therapy, Combination; Enterococcus; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Keratitis, Herpetic; Levofloxacin; Male; Middle Aged; Ofloxacin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis.
Topics: Aged; Anti-Infective Agents; Area Under Curve; Blood Proteins; Drug Delivery Systems; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Protein Binding; Pseudomonas Infections; Sepsis; Staphylococcal Infections | 2003 |
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Floxacillin; Fluoroquinolones; Infusions, Intravenous; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rats; Staphylococcal Infections; Streptococcal Infections; Vancomycin; Viridans Streptococci | 2004 |
Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
Topics: Anti-Infective Agents; Ciprofloxacin; Conjunctivitis, Bacterial; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Keratitis; Levofloxacin; Methicillin; Microbial Sensitivity Tests; Ofloxacin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2004 |
Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Cornea; Drug Resistance, Bacterial; Fluoroquinolones; Keratitis; Levofloxacin; Moxifloxacin; Ofloxacin; Quinolines; Rabbits; Staphylococcal Infections | 2004 |
An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Clindamycin; Community-Acquired Infections; Erythromycin; Female; Humans; Kentucky; Levofloxacin; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxacillin; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Vancomycin | 2005 |
Coadministration of oral levofloxacin with agents that impair its absorption: potential impact on emergence of resistance.
Topics: Administration, Oral; Adsorption; Aged; Anti-Bacterial Agents; Case-Control Studies; Cations, Divalent; Drug Interactions; Drug Resistance, Bacterial; Drug Therapy, Combination; Elements; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Staphylococcal Infections; Staphylococcus; Time Factors | 2005 |
Systemic and local antibiotic prophylaxis in the prevention of Staphylococcus epidermidis graft infection.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Levofloxacin; Male; Methicillin Resistance; Ofloxacin; Polyethylene Terephthalates; Polytetrafluoroethylene; Prosthesis-Related Infections; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus epidermidis; Teicoplanin | 2005 |
Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Ciprofloxacin; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Levofloxacin; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Quinolines; Rabbits; Staphylococcal Infections; Vitreous Body | 2007 |
Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Aza Compounds; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Horses; Humans; Injections, Intravenous; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pneumococcal Infections; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae | 2006 |
Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cloxacillin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Foreign-Body Reaction; Humans; Levofloxacin; Linezolid; Male; Methicillin; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Conservative treatment of staphylococcal prosthetic joint infections in elderly patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Chi-Square Distribution; Debridement; Drug Administration Schedule; Female; Hip Prosthesis; Humans; Joint Prosthesis; Knee Prosthesis; Levofloxacin; Male; Methicillin Resistance; Ofloxacin; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Treatment Failure; Treatment Outcome | 2006 |
The mutant selection window in rabbits infected with Staphylococcus aureus.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Colony Count, Microbial; Diffusion Chambers, Culture; Drug Resistance, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rabbits; Selection, Genetic; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 2006 |
In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Doxycycline; Drug Therapy, Combination; Enzyme Inhibitors; Fosfomycin; Humans; In Vitro Techniques; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Factors compromising the activity of moxifloxacin against intracellular Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Aza Compounds; Cell Line; Extracellular Space; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Levofloxacin; Lysosomes; Monocytes; Moxifloxacin; Ofloxacin; Quinolines; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Role of interleukin-6 in the pathogenesis of an avian model of Staphylococcus aureus arthritis.
Topics: Animals; Anti-Bacterial Agents; Arthritis, Infectious; Chickens; Disease Models, Animal; Interleukin-6; Levofloxacin; Ofloxacin; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Methicillin-sensitive Staphylococcus aureus tricuspid valve endocarditis with annular abscess cured with oral levofloxacin and rifampicin.
Topics: Abscess; Adult; Anti-Bacterial Agents; Cloxacillin; Endocarditis, Bacterial; Fever; Humans; Levofloxacin; Male; Methicillin Resistance; Ofloxacin; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tricuspid Valve | 2007 |
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pneumonia; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Endophthalmitis; Female; Levofloxacin; Male; Microbial Sensitivity Tests; Models, Animal; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin; Vitreous Body | 2008 |
Immunomodulatory effect of gatifloxacin on mouse peritoneal macrophages in vitro and in models of endotoxin-induced rat conjunctivitis and rabbit bacterial keratitis.
Topics: Animals; Anti-Inflammatory Agents; Aza Compounds; Cells, Cultured; Conjunctivitis; Endotoxins; Fluoroquinolones; Gatifloxacin; Immunologic Factors; Keratitis; Levofloxacin; Lipopolysaccharides; Macrophages, Peritoneal; Male; Methicillin Resistance; Mice; Mice, Inbred C3H; Moxifloxacin; Ofloxacin; Quinolines; Rabbits; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tumor Necrosis Factor-alpha | 2008 |
In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and-resistant Staphylococcus aureus strains.
Topics: Acute Disease; Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Female; Kidney; Levofloxacin; Methicillin Resistance; Mice; Ofloxacin; Pyelonephritis; Staphylococcal Infections | 1996 |
Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Endocarditis, Bacterial; Floxacillin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1997 |
Effects of sucrose and silver on Staphylococcus aureus biofilms.
Topics: Anti-Infective Agents; Anti-Infective Agents, Local; Bacterial Adhesion; Biofilms; Blood Coagulation; Colony Count, Microbial; Culture Media; Furunculosis; Humans; Impetigo; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Silver Sulfadiazine; Staphylococcal Infections; Staphylococcus aureus; Sucrose | 1998 |
Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.
Topics: Anti-Infective Agents; Bacterial Proteins; Biological Transport; Ciprofloxacin; Drug Synergism; Humans; Levofloxacin; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Norfloxacin; Ofloxacin; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1999 |
Prophylaxis of local vascular graft infection with levofloxacin incorporated into albumin-sealed dacron graft (LVFX-ALB Graft).
Topics: Albumins; Animals; Anti-Infective Agents; Bacterial Adhesion; Blood Vessel Prosthesis Implantation; Colony Count, Microbial; Disease Models, Animal; Dogs; Humans; Levofloxacin; Ofloxacin; Polyethylene Terephthalates; Rabbits; Staphylococcal Infections | 1999 |
The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; Drug Interactions; Drug Resistance, Microbial; Enzyme Inhibitors; Humans; Levofloxacin; Microbial Sensitivity Tests; Models, Biological; Multidrug Resistance-Associated Proteins; Norfloxacin; Ofloxacin; Omeprazole; Species Specificity; Staphylococcal Infections; Staphylococcus aureus | 1999 |
Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.
Topics: Animals; Aortic Valve; Drug Resistance, Microbial; Endocarditis, Bacterial; Heart Valve Diseases; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus sanguis | 1999 |
Pharmacokinetics and pharmacodynamics of levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid.
Topics: Anti-Infective Agents; Blister; Body Fluids; Granulocytes; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pneumococcal Infections; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors | 2000 |
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection.
Topics: Animals; Blood Vessel Prosthesis; Humans; Levofloxacin; Male; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Prosthesis-Related Infections; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis | 2000 |
Comparative evaluation of oral levofloxacin and parenteral nafcillin in the treatment of experimental methicillin-susceptible Staphylococcus aureus osteomyelitis in rabbits.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Humans; Infusions, Parenteral; Levofloxacin; Methicillin; Nafcillin; Ofloxacin; Osteomyelitis; Penicillins; Rabbits; Staphylococcal Infections; Tibia | 2001 |
Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Disease Models, Animal; Fluoroquinolones; Foreign-Body Reaction; Guinea Pigs; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2002 |
Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Chi-Square Distribution; Confidence Intervals; Cross Infection; Female; Humans; Length of Stay; Levofloxacin; Logistic Models; Macrolides; Male; Methicillin Resistance; Middle Aged; Odds Ratio; Ofloxacin; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus | 2002 |
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model].
Topics: Animals; Blood Vessel Prosthesis Implantation; Cefazolin; Drug Evaluation, Preclinical; Drug Implants; Drug Resistance; Drug Therapy, Combination; Injections, Intraperitoneal; Levofloxacin; Male; Methicillin Resistance; Models, Animal; Ofloxacin; Oxacillin; Premedication; Prostheses and Implants; Prosthesis-Related Infections; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Teicoplanin | 2001 |
[Levofloxacin in the field of dermatology].
Topics: Adolescent; Adult; Animals; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Rats; Skin; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus | 1992 |